Abstract
The 1,4-dihydropyridine nifedipine is a prototypical example of the group of calcium channel blockers that also includes a number of second and third generation agents. These drugs enjoy substantial therapeutic prominence for their cardiovascular actions, including hypertension and angina. These actions are exerted at a specific member of the voltage-gated calcium channel family -the L-type channel. However, it is increasingly clear that the 1,4-dihydropyridine structure is a pharmacophoric template or "privileged structure" that, when appropriately substituted, can exert potent and selective actions at a diverse set of membrane receptors, including ion channels, G protein-coupled receptors and enzymes. This review will summarize the actions of 1,4-dihydropyridines at these receptors and advance the case that the 4-phenyl-1,4-dihydropyridine structure is a particularly versatile drug template. Part I of the review will summarize actions at ion channels and part II will summarize actions at other receptor systems.
| Original language | English |
|---|---|
| Pages (from-to) | 215-223 |
| Number of pages | 9 |
| Journal | Mini-Reviews in Medicinal Chemistry |
| Volume | 3 |
| Issue number | 3 |
| DOIs | |
| State | Published - May 2003 |
Fingerprint
Dive into the research topics of 'The 1,4-dihydropyridine nucleus: a pharmacophoric template part 1. Actions at ion channels.'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver